Eloxatin approved for first line treatment of advanced colorectal cancer

Julia Draznin Maltzman, MD
The Abramson Cancer Center of the University of Pennsylvania
Ultima Vez Modificado: 14 de marzo del 2004

Translation for this article does not exist